PRIMPOL’s protein anchor restarts stalled human DNA copying
Researchers reconstructed how human DNA copying resumes after encountering damage. The enzyme PRIMPOL attached to the machinery that unwinds DNA and supplied a new starting point beyond the obstruction. A single peer-reviewed study combined purified proteins, structural imaging and selected human cells to connect this attachment with successful restart and damage tolerance.
Science··Evening
A new start beyond damaged DNA
Researchers reconstructed the restart of human DNA copying after damage blocked its progress. The enzyme PRIMPOL made a new starting segment beyond the obstruction, allowing synthesis to resume. This single peer-reviewed study, published on November 11, used purified human proteins to rebuild the copying machinery in the laboratory. Restart left a short unfilled stretch behind for later processing, separating continued copying from removal of the original damage.[1]
Anchoring the restart enzyme
Structural imaging showed PRIMPOL attached to the protein complex that unwinds DNA ahead of copying. The position oriented the enzyme towards the strand needing a new start. When researchers disrupted this attachment, restart failed in the reconstructed system even though the enzyme could still initiate synthesis on a simpler template. The interaction linked the restart activity to its correct place in the larger machinery.[1]
Damage tolerance in selected cells
Most new starts on the tested templates occurred within fifty DNA building blocks of the obstruction, although sequence changes altered their distribution. Selected human-cell experiments also connected the protein attachment with tolerance of cisplatin-associated DNA damage. Those cells had a particular genetic background. The findings concern a defined protein system and cell model, describing a mechanism of damage tolerance rather than a treatment tested in patients.[1]
